FDA’s Second-In-Command, Amy Abernethy, Departing Agency

23 Mar 2021

US FDA principal deputy commissioner Amy Abernethy is set to leave the agency by the end of April. The surprise news comes in the midst of the Biden administration still figuring out who they want to lead the FDA.

FDA Deputy Commissioner Amy Abernathy speaking at Reagan-Udall Foundation for FDA.( — FDA Deputy Commissioner Amy Abernathy speaking at the Reagan-Udall Foundation for FDA in May 2019 • Source: Ferdous Al-Faruque

FDA’s Second-In-Command, Amy Abernethy, Departing Agency

More from Regulation

More from Policy & Regulation